BJ
KERX

BlackRock Japan’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

BlackRock Japan’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-238
Closed -$2K – 1415
2015
Q2 		$2K Buy
+238
New +$2.55K ﹤0.01% 1330
2014
Q2 		– Sell
-2,181
Closed -$37K – 1462
2014
Q1 		$37K Buy
+2,181
New +$32.9K ﹤0.01% 1202
2013
Q3 		– Sell
-24,873
Closed -$186K – 1431
2013
Q2 		$186K Buy
+24,873
New +$194K ﹤0.01% 882

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BlackRock Japan's KERX Position: Q3 2015 in Review

BlackRock Japan sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 238 shares — an estimated $2K sold.

BlackRock Japan first reported a position in KERX in Q2 2013 and held it in 3 quarters. The position peaked at $186K in Q2 2013. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • BlackRock Japan reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • BlackRock Japan sold 238 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $2K.
  • BlackRock Japan first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • BlackRock Japan's Keryx Biopharmaceuticals Inc position peaked at $186K in Q2 2013.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on BlackRock Japan's 13F filing for Q3 2015, filed 13 Nov 2015.